<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01938300</url>
  </required_header>
  <id_info>
    <org_study_id>Mg-ROTEM-colorectal ca</org_study_id>
    <nct_id>NCT01938300</nct_id>
  </id_info>
  <brief_title>Magnesium and Rotational Thromboelastometry (ROTEM) in Colorectal Cancer Surgery</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Bundang Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Bundang Hospital</source>
  <brief_summary>
    <textblock>
      Magnesium sulphate is given to the patients during the colorectal cancer surgery under the
      hypothesis that it would attenuate the postoperative hypercoagulability. The investigators
      intend to characterize the changes of coagulation in colorectal cancer patients by using the
      point-of-care device after the infusion of magnesium sulphate.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2011</start_date>
  <completion_date type="Actual">October 2013</completion_date>
  <primary_completion_date type="Actual">October 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change of maximum clot firmness (MCF) of FIBTEM</measure>
    <time_frame>1 day before a operation, 1 hour after finishing a operation, and a postopearative 3 day</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of Clotting time (CT) of INTEM</measure>
    <time_frame>1 day before a operation, 1 hour after finishing a operation, and a postopearative 3 day</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of Clot firmness time (CFT) of INTEM</measure>
    <time_frame>1 day before a operation, 1 hour after finishing a operation, and a postopearative 3 day</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of Alpha angle of INTEM</measure>
    <time_frame>1 day before a operation, 1 hour after finishing a operation, and a postopearative 3 day</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of MCF of INTEM</measure>
    <time_frame>1 day before a operation, 1 hour after finishing a operation, and a postopearative 3 day</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of CT of EXTEM</measure>
    <time_frame>1 day before a operation, 1 hour after finishing a operation, and a postopearative 3 day</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of CFT of EXTEM</measure>
    <time_frame>1 day before a operation, 1 hour after finishing a operation, and a postopearative 3 day</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of Alpha angle of EXTEM</measure>
    <time_frame>1 day before a operation, 1 hour after finishing a operation, and a postopearative 3 day</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of MCF of EXTEM</measure>
    <time_frame>1 day before a operation, 1 hour after finishing a operation, and a postopearative 3 day</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change of Hemoglobin</measure>
    <time_frame>1 day before a operation, 1 hour after finishing a operation, and a postopearative 3 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of Platelet count</measure>
    <time_frame>1 day before a operation, 1 hour after finishing a operation, and a postopearative 3 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of International normalized ratio of prothrombin time</measure>
    <time_frame>1 day before a operation, 1 hour after finishing a operation, and a postopearative 3 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of Activated partial thrombin time</measure>
    <time_frame>1 day before a operation, 1 hour after finishing a operation, and a postopearative 3 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of Fibrinogen</measure>
    <time_frame>1 day before a operation, 1 hour after finishing a operation, and a postopearative 3 day</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">44</enrollment>
  <condition>Colorectal Cancer</condition>
  <arm_group>
    <arm_group_label>Magnesium</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Magnesium sulfate infusion during a operation period.
Infusion regimen:
Bolus 50 mg/kg of magnesium sulfate in 100 ml normal saline over 15 minutes
Infusion 15 mg/kg/h of magnesium sulfate throughout the operation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>administration of normal saline as a same volume of magnesium sulphate as a same method.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Magnesium Sulfate</intervention_name>
    <arm_group_label>Magnesium</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Normal saline</intervention_name>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The patients undergoing a laparoscopic colorectal cancer surgery

        Exclusion Criteria:

          -  Renal disease

          -  Hepatic disease

          -  Neuromuscular disease

          -  Coagulation disorder

          -  Cardiopulmonary disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Seoul National University Bundang Hospital</name>
      <address>
        <city>Seongnam</city>
        <state>Gyeonggi</state>
        <zip>463-707</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 30, 2013</study_first_submitted>
  <study_first_submitted_qc>September 4, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 10, 2013</study_first_posted>
  <last_update_submitted>November 17, 2015</last_update_submitted>
  <last_update_submitted_qc>November 17, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 20, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Bundang Hospital</investigator_affiliation>
    <investigator_full_name>Hyo-Seok Na</investigator_full_name>
    <investigator_title>Dr.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Magnesium Sulfate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

